wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39712486-62554DDA-0C38-407F-A881-CC287A7211C5
Q39712486-62554DDA-0C38-407F-A881-CC287A7211C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39712486-62554DDA-0C38-407F-A881-CC287A7211C5
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
P2860
Q39712486-62554DDA-0C38-407F-A881-CC287A7211C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39712486-62554DDA-0C38-407F-A881-CC287A7211C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
540815441669c05a2e7d17f1c0a827816aca3e74
P2860
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.